Velocity’s research site in New Orleans was founded in 2012 as MedPharmics, and acquired by Velocity in 2022. Since its inception, the site has built a reputation of success conducting trials in Infectious Diseases and Women’s Health, and has completed 50+ vaccine trials. Additionally, our New Orleans team is actively expanding to new therapeutic areas to better serve the diverse population of the greater New Orleans area.
Velocity Clinical Research New Orleans is conveniently located off of S. Norman C Francis Parkway, just down the street from the University Medical Center on Tulane Ave. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The New Orleans team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.